Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11p15.5 imprinted domain

Genomics

Volumn 49, Issue 1, 1998, Pages 38-51

  Cooper, Paul R ^a   Smilinich, Nancy J ^a   Day, Colleen D ^a   Nowak, Norma J ^a   Reid, Laura H ^b   Pearsall, R Scott ^a   Reece, Mark ^c   Prawitt, Dirk ^d   Landers, John ^e   Housman, David E ^e   Winterpacht, Andreas ^d   Zabel, Bernhard U ^d   Pelletier, Jerry ^c   Weissman, Bernard E ^b   Shows, Thomas B ^a   Higgins, Michael J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BECKWITH WIEDEMANN SYNDROME; CHROMOSOME 11P; DNA LIBRARY; DNA POLYMORPHISM; GENE EXPRESSION; GENE LOCATION; GENE STRUCTURE; GENETIC TRANSCRIPTION; GENOME IMPRINTING; HEPATOBLASTOMA; HUMAN; KIDNEY; LIVER; NEPHROBLASTOMA; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SINGLE STRAND CONFORMATION POLYMORPHISM; TISSUE DISTRIBUTION;

EID: 0032054294     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1998.5221     Document Type: Article

References (79)

1. Allard J. D., Bertrand K. P. Sequence of a class E tetracycline resistance gene fromEscherichia coli. J. Bacteriol. 175:1993;4554-4560.
2. Ahmed M., Lyass L., Markham P. N., Taylor S. S., Vazquez-Laslop N., Neyfakh A. A. Two highly similar multidrug transporters ofBacillus subtilis. J. Bacteriol. 177:1995;3904-3910.
3. Baird P. N., Groves N., Haber D. A., Housman D. E., Cowell J. K. Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome. Oncogene. 7:1992a;2141-2149.
4. Baird P. N., Santos A., Groves N., Jadresic L., Cowell J. K. Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome. Hum. Mol. Genet. 1:1992b;301-305.
5. Bardeesy N., Falkoff D., Petruzzi M. J., Nowak N., Zabel B., Adam M., Aguiar M. C., Grundy P., Shows T. B., Pelletier J. Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nature Genet. 7:1994;91-97.
6. Barlow D. P. Competition - A common motif for the imprinting mechanism. EMBO J. 16:1997;6899-6905.
7. Bartolomei M. S., Webber A. L., Brunkow M. E., Tilghman S. M. Epigenetic mechanisms underlying the imprinting of the mouseH19. Genes Dev. 7:1993;1663-1673.
8. Blanchard M. M., Taillon-Miller P., Nowotny P. PCR buffer optimization with uniform temperature regimen to facilitate automation. PCR Methods Appl. 2:1993;234-240.
9. Campbell C. E., Huang A., Gurney A. L., Kessler P. M., Hewitt J. A., Williams B. R. G. Antisense transcripts and protein binding motifs within the Wilms tumour (WT1) locus. Oncogene. 9:1994;583-595.
10. Chenchik A., Moqadam F., Siebert P. Marathon cDNA amplification: A new method for cloning full length cDNAs. CLONTECHniques. X:1995;5-8.
11. Church G. M., Gilbert W. Genomic sequencing. Proc. Natl. Acad. Sci. USA. 81:1984;1991-1995.
12. Crider-Miller S. J., Reid L. H., Higgins M. J., Nowak N. J., Shows T. B., Futreal P. A., Weissman B. E. Novel transcribed sequences within the BWS/WT2 region in 11p15.5: Tissue-specific expression correlates with cancer type. Genomics. 46:1997;355-363.
13. Eccles M. R., Grubb G., Ogawa O., Szeto J., Reeve A. E. Cloning of novel Wilms tumor gene (WT1) cDNAs: Evidence for antisense transcription of WT1. Oncogene. 9:1994;2059-2063.
14. Gavalas A., Zalkin H. Analysis of the chicken GPAT/AIRC bidirectional promoter forde novo. J. Biol. Chem. 270:1995;2403-2410.
15. Haber D. A., Sohn R. L., Buckler A. J., Pelletier J., Call K. M., Housman D. E. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc. Natl. Acad. Sci. USA. 86:1991;9618-9622.
16. Haig D. Do imprinted genes have few and small introns. Bioessays. 18:1996;351-353.
17. Hao Y., Crenshaw T., Moulton T., Newcomb E., Tycko B. Tumor-suppressor activity of H19 RNA. Nature. 365:1993;764-767.
18. Hatada I., Inazawa J., Abe T., Nakayama M., Kaneko Y., Jinno Y., Niikawa N., Ohashi H., Fukushima Y., Iida K., Yutani C., Takahashi S., Chiba Y., Ohishi S., Mukai T. Genomic imprinting of humanKIP2. Hum. Mol. Genet. 5:1996;783-788.
19. Heikklila P., Soininen R., Tryggvason K. Directional regulatory activity of cis-acting elements in the bidirectional α1(IV) and α2(IV) collagen gene promoter. J. Biol. Chem. 268:1993;24677-24682.
20. Henry I., Bonaiti-Pellie C., Chehensse V., Beldjord C., Schwartz C., Utermann G., Junien C. Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature. 351:1991;665-667.
21. Hofmann K., Stoffel W. TMbase - A database of membrane spanning protein segments. Biol. Chem. Hoppe-Seyler. 347:1993;166.
22. Hoovers J. M., Kalikin L. M., Johnson L. A., Alders M., Redeker B., Law D. J., Bliek J., Steenman M., Benedict M., Wiegant J., Lengauer C., Taillonmiller P., Schlessinger D., Edwards M. C., Elledge S. J., Ivens A., Westerveld A., Little P., Mannens M., Feinberg A. P. Multiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragments. Proc. Natl. Acad. Sci. USA. 92:1995;12456-12460.
23. Hopkin K. Beckwith-Wiedemann syndrome: Lone gunman or genetic mob. J. NIH Res. 9:1997;27-29.
24. KIP2. Hum. Mol. Genet. 5:1996;1743-1748.
25. Huang A., Campbell C., Bonetta L., McAndrews-Hill M. S., Chilton-McNeill S., Coppes M. J., Law D. J., Feinberg A. P., Yeger H., Williams B. R. G. Tissue, developmental, and tumor specific expression of divergent transcripts in Wilms tumor. Science. 250:1990;991-994.
26. Hurst L. D., McVean G., Moore T. Imprinted genes have few and small introns. Nature Genet. 12:1996;234-237.
27. John R. M., Surani M. A. Imprinted genes and regulation of gene expression by epigenetic inheritance. Curr. Opin. Genet. Dev. 8:1996;348-353.
28. Joyce J. A., Lam W. K., Catchpoole D. J., Jenks P., Reik W., Maher E. R., Schofield P. N. Imprinting ofIGF2H19. Hum. Mol. Genet. 6:1997;1543-1548.
29. Junien C. Beckwith-Wiedemann syndrome, tumorigenesis and imprinting. Curr. Opin. Genet. Dev. 2:1992;431-438.
30. Koi M., Johnson L. A., Kalikin L. M., Little P. F. R., Nakamura Y., Feinberg A. P. Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. Science. 260:1993;361-364.
31. Koufos A., Grundy P., Morgan K., Aleck K. A., Hadro T., Lampkin B. C., Kalbakji A., Cavenee W. K. Familial Wiedemann-Beckwith syndrome and a second Wilms' tumour locus both map to 11p15.5. Am. J. Hum. Genet. 44:1989;711-719.
32. Kozak M. Structural features in eukaryotic mRNAs that modulate the initiation of translation. J. Biol. Chem. 266:1991;19867-19870.
33. Lee M. P., Hu R.-H., Johnson L. A., Feinberg A. P. Human KVLQT1 gene shows tissue specific imprinting and encompasses Beckwith Wiedemann syndrome chromosomal rearrangements. Nature Genet. 15:1997a;181-185.
34. Lee M. P., DeBaun M., Randhawa G., Reichard B. A., Elledge S. J., Feinberg A. P. Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome. Am. J. Hum. Genet. 61:1997b;304-309.
35. KIP2,. Genes Dev. 9:1995;639-649.
36. Lefebvre S., Burglen L., Reboullet S., Clermont O., Burlet P., Viollet L., Benichou B., Cruaud C., Millasseau P., Zeviani M., Le Paslier D., Frezal J., Cohen D., Weissenbach J., Munnich A., Melki J. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 80:1995;155-166.
37. Leighton P. A, Ingram R. S., Eggenschwiler J., Efstratiadis A., Tilghman S. M. Disruption of imprinting caused by deletion of theH19. Nature. 375:1995;34-39.
38. Little M. H., Prosser J., Condie A., Smith P. J., van Heyningen V., Hastie N. D. Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc. Natl. Acad. Sci. USA. 89:1992;4791-4795.
39. Mannens M., Hoovers J. M. N., Redeker E., Verjaal M., Feinberg A. P., Little P., Boavida M., Coad N., Steenman M., Bliek J., Niikawa N., Tonoki H., Nakamura Y., de Boer E. G., Slater R. M., John R., Cowell J. K., Junien C., Henry I., Tommerup N., Weksberg R., Pueschel S. M., Leschot N. J., Westerveld A. Parental imprinting of human chromosomal region 11p15.3-pter involved in the Beckwith-Wiedemann syndrome and various human neoplasia. Eur. J. Hum Genet. 2:1994;3-23.
40. Matsuoka S., Edwards M. C., Bai C., Parker S., Zhang P., Baldini A., Harper J. W., Elledge S. J. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:1995;650-662.
41. Matsuoka S., Thompson J. S., Edwards M. C., Barlett J. M., Grundy P., Kalikin L. M., Harper J. W., Elledge S. J., Feinberg A. P. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57(KIP2), on chromosome 11p15. Proc. Natl. Acad. Sci. USA. 93:1996;3026-3030.
42. Moulton T., Crenshaw T., Hao Y., Moosikasuwan J., Lin N., Dembitzer F., Hensle T., Weiss L., McMorrow L., Loew T., Kraus W., Gerald W., Tycko B. Epigenetic lesions at theH19. Nature Genet. 7:1994;440-447.
43. Moulton T., Chung W.-Y., Yuan L., Hensle T., Waber P., Nisen P., Tycko B. Genomic imprinting and Wilms' tumor. Med. Pediatr. Oncol. 27:1996;476-483.
44. Neumann B., Barlow D. P. Multiple roles for DNA methylation in gametic imprinting. Curr. Opin. Genet. Dev. 6:1996;159-163.
45. Oettinger M. A., Schatz D. G., Gorka C., Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science. 248:1990;1517-1523.
46. Ogawa O., Eccles M. R., Szeto J., McNoe L. A., Yun K., Maw M. A., Smith P. J., Reeve A. E. Relaxation of insulin like growth factor II gene imprinting implicated in Wilms' tumor. Nature. 362:1993;749-751.
47. KIP2. Am. J. Hum. Genet. 61:1997;295-303.
48. KIP2. Cancer Res. 56:1996;1219-1221.
49. KIP2. Genes Chromosomes Cancer. 17:1996;56-59.
50. Pal N., Wadey R. B., Buckle B., Yeomans E., Pritchard J., Cowell J. K. Preferential loss of maternal alleles in sporadic Wilms' tumour. Oncogene. 5:1990;1665-1668.
51. Pelletier J., Bruening W., Li F. P., Haber D. A., Glaser T., Housman D. E. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature. 353:1991a;431-434.
52. Pelletier J., Bruening W., Kashtan C. E., Mauer S. M., Manivel J. C., Striegel J. E., Houghton D. C., Junien C., Habib R., Fouser L., Fine R. N., Silverman B. L., Haber D. A., Housman D. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell. 67:1991b;437-447.
53. Ping A. J., Reeve A. F., Law D. J., Young M. R., Boehnke M., Feinberg A. P. Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am. J. Hum. Genet. 44:1989;720-723.
54. Qian N., Frank D., O'Keefe D., Dao D., Zhao L., Yuan L., Wang Q., Keating M. T., Walsh C., Tycko B. TheIPL. Hum. Mol. Genet. 6:1997;2021-2029.
55. Rainier S, Johnson L. A., Dobry C. J., Ping A. J., Grundy P. E., Feinberg A. P. Relaxation of imprinted genes in human cancer. Nature. 362:1993;747-749.
56. Reid L. H., West A., Gioeli D. G., Phillips K. K., Kelleher K. F., Araujo D., Stanbridge E. J., Dowdy S. F., Gerhard D. S., Weissman B. E. Localization of a tumor suppressor gene to 11p15.5 using the G401 Wilms' tumor assay. Hum. Mol. Genet. 5:1996a;239-247.
57. Reid L. H., Crider-Miller S. J., West A., Lee M. H., Massague J., Weissman B. E. Genomic organization of the human p57KIP2 gene and its analysis in the G401 Wilms' tumor assay. Cancer Res. 56:1996b;1214-1218.
58. Reid L. H., Davies C., Cooper P. R., Crider-Miller S. J., Sait S. N. J., Nowak N. J., Evans G., Stanbridge E. J., de Jong P., Shows T. B., Weissman B. E., Higgins M. J. A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/WT2 region. Genomics. 43:1997;366-375.
59. Reik W., Maher E. R. Imprinting in clusters: Lessons from Beckwith-Wiedemann syndrome. Trends Genet. 13:1997;330-334.
60. Rodriguez P., Munroe D., Prawitt D., Chu L. L., Bric E., Kim J., Reid L. H., Davies C., Nakagama H., Loebbert R., Winterpacht A., Petruzzi M. J., Higgins M. J., Nowak N., Evans G., Shows T., Weissman B. E., Zabel B., Housman D. E., Pelletier J. Functional characterization of human nucleosome assembly protein 1 (NAPIL4) suggests a role as a histone chaperone. Genomics. 44:1997;365-367.
61. Roy N., Mahadevan M. S., McLean M., Shutler G., Yaraghi Z., Farahani R., Baird S., Besner-Johnston A., Lefebvre C., Kang X., Salih M., Aubry H., Tamai K., Guan X., Ioannou P., Crawford T. O., de Jong P. J., Surh L., Ikeda J. E., Korneluk R. G., MacKenzie A. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell. 80:1995;167-178.
62. Sait S. N. J., Nowak N. J., Singh-Kahlon P., Weksberg R., Squire J., Shows T. B., Higgins M. J. Localization of Beckwith-Wiedemann and rhabdoid tumor chromosome rearrangements to a defined interval in chromosome band 11p15.5. Genes Chromosomes Cancer. 11:1994;97-105.
63. Scrable H., Cavenee W., Ghavimi F., Lovell M., Morgan K., Sapienza C. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genomic imprinting. Proc. Natl. Acad. Sci. USA. 86:1989;7480-7484.
64. Seizinger B., Klinger H. P. J., Junien C., Nakamura Y., LeBeau M., Cavenee W., Emmanueal B., Ponder B., Naylor S., Louis D., Menon A., Newsham I., Decker J., Knebling M., Henry I., Deimling A. V. Report of the Committee on Chromosome and Gene Loss in Human Neoplasia. Cytogenet. Cell. Genet. 58:1991;1080-1096.
65. Schroeder W. T., Chao L. Y., Dao D. D., Strong L. C., Pathak S., Riccardi V., Lewis W. H., Saunders G. F. Non-random loss of maternal chromosome 11 alleles in Wilms tumors. Am. J. Hum. Genet. 40:1987;413-420.
66. Steenman M. J., Rainier S., Dobry C. J., Grundy P., Horon I. L., Feinberg A. P. Loss of imprinting ofIGF2H19. Nature Genet. 7:1994;433-439.
67. Sun F.-L., Dean W. L., Kelsey G., Allen N. D., Reik W. Transactivation ofIGF2. Nature. 389:1997;809-815.
68. KIP2. Cancer Res. 56:1996;5723-5727.
69. Tsang P., Gilles F., Yuan L., Kuo Y. H., Lupu F., Samara G., Moosikasuwan J., Goye A., Zelenetz A. D., Selleri L., Tycko B. A novel L23-related gene 40 kb downstream of the imprintedH19. Hum. Mol. Genet. 4:1995;1499-1507.
70. Vu T. H., Hoffman A. R. Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature. 371:1994;714-717.
71. Wang Q., Curran M. E., Splawski I., Burn T. C., Millholland J. M., Van Raay T. J., Shen J., Timothy K. W., Vincent G. M., de Jager T., Schwartz P. J., Toubin J. A., Moss A. J., Atkinson D. L., Landes G. M., Connors T. D., Keating M. T. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nature Genet. 12:1996;17-23.
72. Weksberg R., Shen D. R., Fei Y. L., Song Q. L., Squire J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nature Genet. 5:1993;143-150.
73. Weksberg R., Squire J. A. Molecular biology of Beckwith-Wiedemann syndrome. Med. Pediatr. Oncol. 27:1996;462-469.
74. Wright K. L., White L. C., Kelly A., Beck S., Trowsdale J., Ting J. P.-Y. Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J. Exp. Med. 181:1995;1459-1471.
75. Wutz A., Smrka O. W., Schwelfer N., Schellander K., Wagner E. F., Barlow D. P. Imprinted expression of theIgf2r. Nature. 389:1997;745-749.
76. Yan Y., Frisen J., Lee M. H., Massague J., Barbacid M. Ablation of the CDK inhibitor p57KIP2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11:1997;973-983.
77. Yeger H., Cullinane C., Flenniken A., Huang A., Chilton-McNeil S., Bonetta L., Campbell C., McGrews-Hill M., Coppes M., Greenberg M., Thorner P., Williams B. R. G. Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes. Cell Growth Differ. 3:1992;855-864.
78. KIP2. Nature. 387:1997;151-158.
79. Zhang J., Madden T. L. PowerBLAST: A new network BLAST application for interactive or automated sequence analysis and annotation. Genome Res. 7:1997;649-656.